Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19048795 | 0.83 | PGK1 (0.33) | AGPAT2PGK1 | |
| SCHEMBL11113555 | 0.67 | PGK1 (0.37) | AGPAT2PGK1 | |
| SCHEMBL9852614 | 0.62 | GFER (0.47) | — | |
| SCHEMBL11113691 | 0.62 | LOXL2 (0.48) | AGPAT2 | |
| SCHEMBL11117595 | 0.62 | PTGS1 (0.47) | AGPAT2PGK1 | |
| SCHEMBL9852620 | 0.58 | GAA (0.35) | — | |
| SCHEMBL4592760 | 0.57 | PGK1 (0.43) | PGK1 | |
| SCHEMBL6729801 | 0.57 | MAOA (0.43) | PGK1 | |
| SCHEMBL9271367 | 0.57 | PGK1 (0.43) | PGK1 | |
| SCHEMBL7074465 | 0.57 | PTGS1 (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170036969-A1 | NITRIFICATION INHIBITORS | BASF SE (DE) | 2017-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170036969-A1 | NITRIFICATION INHIBITORS | NOS1, NOS2, NOS3 | AGPAT2 1047/4885PGK1 1520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.